T. Kosjek et al.
compounds by a dashed arrow and classifies them into a group of
compounds formed strictly by a photocatalytic transformation of
EtBP or AcBP, respectively. Except for TP-18, which was subjected
to a side-chain hydroxylation, the remaining six photocatalytic
TPs of EtBP (TP-12 to TP-17) involve a hydroxyl group positioned
on the benzophenone ring system. Similarly, the photocatalytic
TPs of AcBP were hydroxylated either on the A-ring (TP-21 and
TP-22) or on the B-ring (TP-19 and TP-20) of the benzophenone
ring system. This finding is in agreement with Hayashi et al.,[25]
who suggests an enhanced hydroxylation of benzophenone ring
system in the presence of H2O2. Such transformations may not
only occur during water treatment but also in the environment,
where photosensitisers such as humic acids generate reactive
oxygen species causing the ring hydroxylation of benzophenone
derivatives. Benzophenone is a suspected endocrine-disrupting
chemical.[25] Whereas the estrogenic activity was not shown for
the compound itself, it was found that benzophenone acquired
estrogenic activity after ring hydroxylation.[25] As evident in
Fig. 2, the ring hydroxylation occurred in 11 of 22 identified
TPs, and there exists a strong indication that these compounds
are endocrine disruptors, which calls for further estrogenic activity
testing.
Silvia Pirsˇ (Jozˇef Stefan Institute, Slovenia), Dr Oliver Bajt (National
Institute of Biology, Marine Biological Station, Slovenia), Dr David
Heath (Jozˇef Stefan International Postgraduate School, Ljubljana,
Slovenia), Prof. Jurij Svete and Rok Prebil (Faculty of Chemistry and
Chemical Technology, University of Ljubljana, Slovenia).
REFERENCES
[1] R. F. Borne. In Principles of Medicinal Chemistry, 4th ed., T. L. Lemke,
D. A. Williams, W. O. Foye (Eds). Williams & Wilkins: PA, USA, 1995,
535.
[2] European Medicines Agency, Committee for Medicinal Products
for Human Use (CHMP), Press release: European Medicines
Agency confirms positive benefit-risk balance of topical formu-
lations of ketoprofen. European Medicines Agency: 2010,
EMA/CHMP/465633/2010.
[3] S. Ophaswongse, H. Maibach. Topical nonsteroidal antiinflamma-
tory drugs: allergic and photoallergic contact dermatitis and
phototoxicity. Contact Dermatitis. 1993, 29, 57.
[4] M. C. Marguery, N. Chouini-Lalanne, J. C. Ader, N. Paillous. Com-
parison of the DNA damage photoinduced by fenofibrate and
ketoprofen, two phototoxic drugs of parent structure. Photochem.
Photobiol. 1998, 68, 679.
[5] T. Kosjek, E. Heath, A. Krbavcˇicˇ. Determination of non-steroidal anti-
inflammatory drug (NSAIDs) residues in water samples. Environ. Int.
2005, 31, 679.
Nevertheless, it should be stressed that the proposed UV
breakdown scheme is configured based on treatment exper-
iments using only three reference standards. Therefore, the
proposed breakdown scheme cannot be regarded as complete
and warrants confirmation by reference standards of the remain-
ing TPs.
[6] N. M. Vieno, T. Tuhkanen, L. Kronberg. Seasonal variation in the
occurrenceofpharmaceuticalsineffluentsfromasewagetreatment
plantandintherecipientwater. Environ.Sci.Technol. 2005, 39, 8220.
[7] A. Lahoz, D. Hernandez, M. A. Miranda, J. Perez-Prieto, I. M. Morera,
J. V. Castell. Antibodies directed to drug epitopes to investigate the
structure of drug-protein photoadducts. Recognition of a common
photobound substructure in tiaprofenic acid/ketoprofen cross-
photoreactivity. Chem. Res. Toxicol. 2001, 14, 1486.
[8] A. Radschuweit,H.-H. Ruttinger,P. Nuhn,W. Wohlrab,Chr. Huschka.
UV-induces formation of hydrogen peroxide based on the
photochemisty of ketoprofen. Photochem. Photobiol. 2001, 73, 119.
[9] F. Bosca, M. A. Miranda. Photosensitizing drugs containing benzo-
phenone chromophore. J. Photochem. Photobiol. B, 1998, 43, 1.
[10] F. Bosca´, M. A. Miranda, G. Carganico, D. Mauleon. Photochemical
and photobiological properties of ketoprofen associated with the
benzophenone chromophore. Photochem. Photobiol. 1994, 60, 96.
[11] A. Nakajima, M. Tahara, Y. Yoshimura, H. Nakazawa. Determination
of free radicals generated from light exposed ketoprofen.
J. Photochem. Photobiol. A, 2005, 174, 89.
[12] F. Bosca, M. L. Marın, M. A. Miranda. Photoreactivity of the non-
steroidal anti-inflammatory 2-arylpropionic acids with photosensi-
tizing side effects. Photochem. Photobiol. 2001, 74, 637.
[13] F. Bosca, G. Carganicob, J. V. Castell, M. J. Gomez-Lechon,
D. Hernandez, D. Mauleon, L. A. Martinez, M. A. Miranda. Evaluation
of ketoprofen (R, S and R/S) phototoxicity by a battery of in vitro
assays. J. Photochem. Photobiol. B, 1995, 31, 133.
[14] K. A. K. Musa, J. M. Matxain, L. A. Eriksson. Mechanism of photo-
induced decomposition of ketoprofen. J. Med. Chem. 2007, 50,
1735.
[15] C. Prakash, C. L. Shaffer, A. Nedderman. Mass Spectrom. Rev. 2007,
26, 340.
[16] T. Kosjek. Occurrence, fate and removal of pharmaceutical residues
in water treatment. Doctoral dissertation. Ljubljana Jozˇef Stefan
International Postgraduate School, 2009.
[17] K. L. Woo, J. I. Kim. New hydrolysis method for extremely small
amount of lipids and capillary gas chromatographic analysis as
N(O)-tert.-butyldimethylsilyl fatty acid derivatives compared with
methyl ester derivatives. J. Chromatogr. A, 1999, 862, 199.
[18] M. Farre´, M. Petrovic´, D. Barcelo´. Recently developed GC/MS and
LC/MS methods for determining NSAIDs in water samples. Anal.
Bioanal. Chem. 2007, 387, 1203.
CONCLUSIONS
This study highlights the transformation of the widely used
pharmaceutical KP under exposure to UV irradiation. Using com-
plementary chromatographic and mass spectrometric techniques,
i.e. gas chromatography coupled to single quadrupole or ion trap
mass spectrometry and liquid chromatography hyphenated with
QqToF mass spectrometry, we were able to propose chemical
structures of 22 TPs of KP, 18 of which are novel. The identi-
fied compounds were used to construct a breakdown pathway
showing that, in given experimental conditions, neither UV nor
the photocatalytic treatment led to a complete mineralisation of
the parent compound KP. Instead, 20 of the TPs retained the
benzophenone moiety, which causes photo-allergic reactions. Ad-
ditionally, since benzophenone derivatives may also be formed
in the aqueous environment or during water treatment, such
symptoms can be generated after contact with environmental or
tap water containing such compounds. Another risk arises from
hydroxylated benzophenones formed during the photocatalytic
transformation of KP, since they show a potential estrogenic
effect. Hopefully, this study will increase attention into the trans-
formation of pharmaceuticals and possible risks related to their
presence in the environment, which should encourage further
research into more efficient treatment technologies to limit the
entrance of such compounds into the environmental or drinking
waters.
[19] B. W. Brooks, C. K. Chambliss, J. K. Stanley, A. Ramirez. Determina-
tion of select antidepressants in fish from an effluent dominated
stream. Environ. Toxicol. Chem. 2005, 24, 464.
Acknowledgements
[20] I. Kim, N. Yamashita, H. Tanaka. Performance of UV and UV/H2O2
processesfortheremovalofpharmaceuticalsdetectedinsecondary
effluentofasewagetreatmentplantinJapan.J.Hazard.Mater.2009,
166, 1134.
The authors kindly acknowledge the financial support given by
the Slovenian Research Agency (Program group P1-0143). For
their support and helpful advice the authors are grateful to Ms
c
wileyonlinelibrary.com/journal/jms
Copyright ꢀ 2011 John Wiley & Sons, Ltd.
J. Mass. Spectrom. 2011, 46, 391–401